Irinotecan: New Results in the Combination Chemotherapy of Colorectal Cancer

Irinotecan is one of the newer cytostatic agents which have a clinically relevant antineoplastic activity in colorectal cancer. As single-agent irinotecan induced an overall objective response rate of